C2-15358. Investigational New Drugs: Export Requirements for Unapproved New Drug Products

[Federal Register Volume 67, Number 129 (Friday, July 5, 2002)]
[Corrections]
[Page 44931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C2-15358]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 312

[Docket No. 00N-1663]
RIN 0910-AA61


Investigational New Drugs: Export Requirements for Unapproved New 
Drug Products

Correction

    In proposed rule document 02-15358 beginning on page 14642 in the 
issue of Wednesday, June 19, 2002, make the following corrections:
    1. On page 41644, in the second column, in the first paragraph, in 
the eight and tenth lines from the bottom, ``802[copy]'' should read 
``802(c)''.
    2. On page 41645, in the first column, in the last paragraph, in 
the first line, ``Sec. 312.110[copy]'' should read ``Sec. 312.110(c)''.
    3. On page 41646, in the first column, in the last paragraph, in 
the third, sixth, and 15th lines ``802[copy]'' should read ``802(c)''.
    4. On the same page, in the second column, in the first complete 
paragraph, in the 12th line, ``802[copy]'' should read ``802(c)''.

[FR Doc. C2-15358 Filed 7-3-02; 8:45 am]
BILLING CODE 1505-01-D